Bridgeway Capital Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Bridgeway Capital Management’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,600	Closed	-$6.79K	–	1453
2022 Q4	$6.79K	Sell	15,600 -89,800	-85%	-$29.1K	﹤0.01%	1360
2022 Q3	$30K	Sell	105,400 -50,000	-32%	-$17.1K	﹤0.01%	1377
2022 Q2	$56K	Sell	155,400 -89,500	-37%	-$37.1K	﹤0.01%	1277
2022 Q1	$164K	Sell	244,900 -100,000	-29%	-$84.9K	﹤0.01%	1201
2021 Q4	$445K	Sell	344,900 -69,000	-17%	-$122K	0.01%	1013
2021 Q3	$898K	Buy	413,900 +115,600	+39%	+$251K	0.02%	858
2021 Q2	$814K	Sell	298,300 -20,000	-6%	-$49.7K	0.01%	923
2021 Q1	$831K	Buy	+318,300	New	+$900K	0.02%	929

Other funds holding SIOX

JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return

CIA

Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Bridgeway Capital Management's SIOX Position: Q1 2023 in Review

Bridgeway Capital Management sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q1 2023, closing a stake of 15,600 shares — an estimated $6.79K sold.

Bridgeway Capital Management first reported a position in SIOX in Q1 2021 and held it in 8 quarters. The position peaked at $898K in Q3 2021. 4 funds tracked by Wall St. Rank hold SIOX as of Q1 2023.

Bridgeway Capital Management reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Bridgeway Capital Management sold 15,600 Sio Gene Therapies Inc. Common Stock shares in Q1 2023, an estimated $6.79K.
Bridgeway Capital Management first reported a position in Sio Gene Therapies Inc. Common Stock in Q1 2021 and held it in 8 quarters.
Bridgeway Capital Management's Sio Gene Therapies Inc. Common Stock position peaked at $898K in Q3 2021.
4 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q1 2023.

Based on Bridgeway Capital Management's 13F filing for Q1 2023, filed 15 May 2023.